alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                         1262168
<SECURITIES>                                         0
<RECEIVABLES>                                   176458
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               1441791
<PP&E>                                        19041247
<DEPRECIATION>                                 5648835
<TOTAL-ASSETS>                                22063534
<CURRENT-LIABILITIES>                           571598
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                    18042748
<TOTAL-LIABILITY-AND-EQUITY>                  22063534
<SALES>                                         145558
<TOTAL-REVENUES>                                841776
<CGS>                                                0
<TOTAL-COSTS>                                    76825
<OTHER-EXPENSES>                                190149
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               36125
<INCOME-PRETAX>                                 538677
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             538677
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    538677
<EPS-PRIMARY>                                     9.09
<EPS-DILUTED>                                     9.09
        

</TABLE>
38219.

#### RAPER v. SMITH.

Decided November 3, 1960.

*Vernon W. Duncan,*for plaintiff in error.

*Raymond Reed, Robert K. Ballew,*contra.

Jordan, Judge.

The judgment of this court *(Raper v. Smith,*101 Ga. App. 557, 115 S. E. 2d 234), affirming the trial court’s overruling of the general demurrer of the defendant, having been reversed by the Supreme Court of Georgia on certiorari *(Raper v. Smith,*216 Ga. 326, 116 S. E. 2d 554), the said judgment of this court is vacated and the judgment of the trial court overruling the general demurrer is reversed in accordance' with the judgment of the Supreme Court.

*Judgment reversed.*

*Townsend, P. J., Carlisle and Frankum, JJ., concur.*
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 411 Engrossed in House (EH)]

<DOC>
H. Res. 411

                In the House of Representatives, U. S.,

                                                         June 27, 2017.
Whereas on June 14, 2017, an armed gunman opened fire at a practice for the 
        annual Congressional Baseball Game for Charity, wounding five 
        individuals;
Whereas Members of the House are understandably concerned about the security of 
        their staff and the constituents they serve, as well as their personal 
        security;
Whereas the Members' Representational Allowance (MRA) is available for ordinary 
        and necessary expenses associated with security measures; and
Whereas heightened security concerns necessitate an adjustment in the MRA to 
        provide Members with additional resources: Now, therefore, be it
    Resolved, That pursuant to section 1(b) of House Resolution 1372, Ninety-
fourth Congress, agreed to July 1, 1976, as enacted into permanent law by 
section 101 of the Legislative Branch Appropriation Act, 1977 (2 U.S.C. 4314), 
the Members' Representational Allowance applicable as of the date of the 
adoption of this resolution for each Member of the House of Representatives 
(including the Delegates and Resident Commissioner to the Congress) is increased 
by $25,000, to be available through January 2, 2018.
            Attest:

                                                                          Clerk.
```
# L_2018184EN.01000101.xml

| 20.7.2018 | EN | Official Journal of the European Union | L 184/1 |
| --- | --- | --- | --- |

20.7.2018

EN

Official Journal of the European Union

L 184/1

---

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1025

of 19 July 2018

amending Council Regulation (EC) No 1210/2003 concerning certain specific restrictions on economic and financial relations with Iraq

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Council Regulation (EC) No 1210/2003 of 7 July 2003 concerning certain specific restrictions on economic and financial relations with Iraq and repealing Regulation (EC) No 2465/96 (1), and in particular Article 11(b) thereof,

Whereas:

| (1) | Annex III to Regulation (EC) No 1210/2003 lists public bodies, corporations and agencies and natural and legal persons, bodies and entities of the previous government of Iraq covered by the freezing of funds and economic resources that were located outside Iraq on the date of 22 May 2003 under that Regulation. |
| --- | --- |

(1)

Annex III to Regulation (EC) No 1210/2003 lists public bodies, corporations and agencies and natural and legal persons, bodies and entities of the previous government of Iraq covered by the freezing of funds and economic resources that were located outside Iraq on the date of 22 May 2003 under that Regulation.

| (2) | On 13 July 2018, the Sanctions Committee of the United Nations Security Council decided to remove two entries from the list of persons or entities to whom the freezing of funds and economic resources should apply. |
| --- | --- |

(2)

On 13 July 2018, the Sanctions Committee of the United Nations Security Council decided to remove two entries from the list of persons or entities to whom the freezing of funds and economic resources should apply.

| (3) | Annex III to Regulation (EC) No 1210/2003 should therefore be amended accordingly, |
| --- | --- |

(3)

Annex III to Regulation (EC) No 1210/2003 should therefore be amended accordingly,

HAS ADOPTED THIS REGULATION:

Article 1

Annex III to Regulation (EC) No 1210/2003 is amended as set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 19 July 2018.

For the Commission,

On behalf of the President,

Head of the Service for Foreign Policy Instruments

---

(1)  
  OJ L 169, 8.7.2003, p. 6.

1

---

ANNEX

In Annex III, the following entries are deleted:

| | ‘62. | IRAQI LIFE INSURANCE COMPANY. Addresses: (a) Aqaba Bin Nafie Square, P.O. Box 989, Baghdad, Iraq; (b) P.O. Box 989, Karradah Al Sharkiya, Baghdad, Iraq.’ |
| --- | --- | --- |

‘62.

| | ‘96. | NATIONAL INSURANCE COMPANY [IRAQ]. Addresses: (a) Khullani Street, P.O. Box 248, Baghdad, Iraq; (b) Aman Building, Khullani Square, Baghdad, Iraq.’ |
| --- | --- | --- |

‘96.

---
<TABLE> <S> <C>


<ARTICLE>     5
<LEGEND>

"This schedule contains summary financial information extracted from Banyan
Strategic Land Fund II's Form 10QSB for the three months ended March 31,
1997 and is qualified in its entirety by reference to such Form 10QSB."

</LEGEND>
       
<S>                     <C>
<PERIOD-TYPE>           3-MOS
<FISCAL-YEAR-END>       DEC-31-1997
<PERIOD-END>            MAR-31-1997
<CASH>                            666,428 
<SECURITIES>                         0    
<RECEIVABLES>                   1,168,515 
<ALLOWANCES>                         0    
<INVENTORY>                          0    
<CURRENT-ASSETS>                  799,943 
<PP&E>                         14,155,259 
<DEPRECIATION>                       0    
<TOTAL-ASSETS>                 16,595,359 
<CURRENT-LIABILITIES>             508,391 
<BONDS>                              0    
<COMMON>                       16,086,968 
<PREFERRED-MANDATORY>                0    
<PREFERRED>                          0    
<OTHER-SE>                           0    
<TOTAL-LIABILITY-AND-EQUITY>   16,595,359 
<SALES>                              0    
<TOTAL-REVENUES>                   20,138 
<CGS>                                0    
<TOTAL-COSTS>                        0    
<OTHER-EXPENSES>                  397,432 
<LOSS-PROVISION>                     0    
<INTEREST-EXPENSE>                   0    
<INCOME-PRETAX>                  (377,294)
<INCOME-TAX>                         0    
<INCOME-CONTINUING>              (377,294)
<DISCONTINUED>                       0    
<EXTRAORDINARY>                      0    
<CHANGES>                            0    
<NET-INCOME>                     (377,294)
<EPS-PRIMARY>                        (.04)
<EPS-DILUTED>                        (.04)
        



</TABLE>
§ 171.130 Procedure for amending and repealing tolerances or exemptions from tolerances. ( a ) The Commissioner, on his own initiative or on the petition of any interested person, pursuant to part 10 of this chapter, may propose the issuance of a regulation amending or repealing a regulation pertaining to a food additive or granting or repealing an exception for such additive.
( b ) Any such petition shall include an assertion of facts, supported by data, showing that new information exists with respect to the food additive or that new uses have been developed or old uses abandoned, that new data are available as to toxicity of the chemical, or that experience with the existing regulation or exemption may justify its amendment or repeal. New data shall be furnished in the form specified in §§ 171.1 and 171.100 for submitting petitions.
[42 FR 14491, Mar. 15, 1977, as amended at 42 FR 15674, Mar. 22, 1977]
### Schaeffer, John From : Lynch, David Sent: To: Thursday, October 01 , 2015 5:07PM Schaeffer, John Subject: RE: 68610-90-2 HPV3 RE : Status Hello John, As I discussed with you earlier I found a read across approach on the ECHA website for 68610-90-2 with Ready Biodegradability data on 2-Butendioic acid (E) -, di-C12 alkylester and 2 Ready Biodegradability tests that had been extended to 60 days on Ditetradecyl fumerate (2-Butenedioic acid (2E)-, 1,4-ditetradecyl ester) and 2- Butenedioic acid (E)-, di-C18-22-alkyl esters
. All were rated "reliable with restrictions".http://apps.echa.europa.eu/registered/data/dossiers/DISS-dffb4072-e3f5-47ae-e044-00144f67d031/DISSdffb4072-e3f5-47ae-e044-00144f67d031 DISS-dffb4072-e3f5-47ae-e044-00144f67d031.html In addition I have reviewed the redacted German translation ofthe biodegradation study on the surrogate chemical provided. Due to CBI constraints Iwill not reveal the identityofthe surrogate chemical. The surrogate chemical was tested for aerobic biodegradability usingthe BODIS method, similarto an OECD 301 type Ready Biodegradability tests and suitable for poorly water soluble chemicals. While this is not, strictly speaking, a Ready Biodegradability test, the results give an indication ofthe ease ofaerobic biodegradation under relatively stringent conditions. There were some issues with the measured chemical oxygen demand of thetest substances and variability between test replicates, but with those acknowledgements Ithinkthe study is acceptable

. The results indicated a mean value (n=3) of67% biodegradation in 28 days based on chemical oxygen demand and 60% biodegradation based on theoretical oxygen demand. Given the information available to characterize the Ready Biodegradability of68610-90-2 I recommend we drop the requirement for Ready Biodegradation testing on 68610-90-2 based on the ECHA read across and the surrogate chemical BODIS study. Please let me know if I need to putthis in a 

### memo, or ifthis e-mail is sufficient. Let me know ifyou have any questions. Dave

David G Lynch Assessment Branch 5 Risk Assessment Division Mail Code 7403M Office of Pollution Prevention and Toxcs 1200 Pennsylvania Ave NW Washington, DC 20460 Office: 202-564-8532 Fax: 202-564-8892 1
###### Editorial Note on Part 17

#### Editorial Note:

Nomenclature changes to part 17 appear at 68 FR 24879, May 9, 2003, and at 88 FR 45065, July 14, 2023.

#### § 17.2 Maximum penalty amounts.

The maximum civil money penalties associated with the statutory provisions authorizing civil money penalties under the Federal Food, Drug, and Cosmetic Act or the Public Health Service Act can be found at 45 CFR part 102. The table of these maximum civil money penalties can be found at 45 CFR 102.3.

[81 FR 62358, Sept. 9, 2016]
**EXHIBIT 32.1**

 

**CERTIFICATIONPURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

Inconnection with the Quarterly Report of National Medical Health Card Systems, Inc.(the “Company”) on Form 10-Q/A for the period ending December 31, 2005 asfiled with the Securities and Exchange Commission on the date hereof (the “Report”),I, James F. Smith, President and Chief Executive Officer of the Company,certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

(1) the Report fully complies with the requirements of section 13(a) or15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) the information contained in the Report fairly presents,in all material respects, the financial condition and result of operations ofthe Company.

 
| /s/ James F. Smith                                                  |   |
|---------------------------------------------------------------------|--------|
| James F. Smith                                                      |
| President and Chief Executive Officer (Principal Executive Officer) |
| September 15,  2006                                            |

 

This certification accompanies this Report on Form 10-Q/A pursuant toSection 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to theextent required by such Act, be deemed filed by the Company for purposes ofSection 18 of the Securities Exchange Act of 1934, as amended (the"Exchange Act"). Such certification will not be deemed to beincorporated by reference into any filing under the Securities Act of 1933, asamended, or the Exchange Act, except to the extent that the Companyspecifically incorporates it by reference.

 

----
Editorial Note on Part 17
Editorial Note: Nomenclature changes to part 17 appear at 68 FR 24879, May 9, 2003, and at 88 FR 45065, July 14, 2023.

§ 17.15 Parties to the hearing. ( a ) The parties to the hearing shall be the respondent and the Center(s) with jurisdiction over the matter at issue. No other person may participate.
( b ) The parties may at any time prior to a final decision by the entity deciding any appeal agree to a settlement of all or a part of the matter. The settlement agreement shall be filed in the docket and shall constitute complete or partial resolution of the administrative case as so designated by the settlement agreement. The settlement document shall be effective upon filing in the docket and need not be ratified by the presiding officer or the Commissioner of Food and Drugs.
( c ) The parties may be represented by counsel, who may be present at the hearing.
223 So.2d 872

#### MICHIGAN WISCONSIN PIPE LINE COMPANY v. SUGARLAND DEVELOPMENT CORPORATION and Jessie L. Angelle.

No. 49914.

June 27, 1969.

In re: Michigan Wisconsin Pipe Line Company applying for certiorari or writ of review, to the Court of Appeal, Third Circuit, Parish of St. Martin. 221 So.2d 593.

The application is denied. According to the facts of the case, as found to be by the Court of Appeal there appears no error of law in the judgment complained of.
§ 146.121 Frozen concentrate for artificially sweetened lemonade. ( a ) Frozen concentrate for artificially sweetened lemonade conforms to the definition and standard of identity prescribed for frozen concentrate for lemonade by § 146.120, except that in lieu of nutritive sweeteners it is sweetened with one or more of the artificial sweetening ingredients listed in and complying with the requirements of parts 172, 180 or 184 of this chapter, and the soluble solids specifications prescribed in § 146.120(a) do not apply. When the product is diluted according to directions which shall appear on the label, the acidity of the artificially sweetened lemonade, calculated as anhydrous citric acid, shall be not less than 0.70 gram per 100 milliliters. It may contain one or more safe and suitable dispersing ingredients serving the function of distributing the lemon oil throughout the food. It may also contain one or more safe and suitable thickening ingredients. Such dispersing and thickening ingredients are not food additives as defined in section 201(s) of the Federal Food, Drug, and Cosmetic Act; or if they are food additives as so defined, they are used in conformity with regulations established pursuant to section 409 of the act.
( b ) [Reserved]
( c ) The name of the food is “Frozen concentrate for artificially sweetened lemonade”. The words “artificially sweetened” shall be of the same size and style of type as the word “lemonade”.
( d ) If an optional thickening or dispersing ingredient referred to in paragraph (a) of this section is used, the label shall bear the statement “______ added” or “with added ______”, the blank being filled in with the common name of the thickening or dispersing agent used. Such statement shall be set forth on the label with such prominence and conspicuousness as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase.
( e ) Frozen concentrate for artificially sweetened lemonade is labeled to conform to the labeling requirements prescribed for foods which purport to be or are represented for special dietary use by regulations promulgated pursuant to section 403(j) of the act.
( f ) *Label declaration.* Each of the ingredients used in the food shall be declared on the label as required by the applicable sections of parts 101 and 130 of this chapter.
[42 FR 14433, Mar. 15, 1977, as amended at 58 FR 2881, Jan. 6, 1993]
35
#### § 1312.29 Domestic release prohibited.

An exporter or a forwarding agent acting for an exporter must either deliver the controlled substances to the port or border, or deliver the controlled substances to a bonded carrier approved by the consignor for delivery to the port or border, and may not, under any other circumstances, release a shipment of controlled substances to anyone, including the foreign consignee or his agent, within the United States.
§ 123.10 Training. At a minimum, the following functions shall be performed by an individual who has successfully completed training in the application of HACCP principles to fish and fishery product processing at least equivalent to that received under standardized curriculum recognized as adequate by the U.S. Food and Drug Administration or who is otherwise qualified through job experience to perform these functions. Job experience will qualify an individual to perform these functions if it has provided knowledge at least equivalent to that provided through the standardized curriculum. ( a ) Developing a HACCP plan, which could include adapting a model or generic-type HACCP plan, that is appropriate for a specific processor, in order to meet the requirements of § 123.6(b);
( b ) Reassessing and modifying the HACCP plan in accordance with the corrective action procedures specified in § 123.7(c)(5), the HACCP plan in accordance with the verification activities specified in § 123.8(a)(1), and the hazard analysis in accordance with the verification activities specified in § 123.8(c); and
( c ) Performing the record review required by § 123.8(a)(3); The trained individual need not be an employee of the processor.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of the Treasury

###### Fiscal Service

# AGENCY:

Financial Management Service, Fiscal Service, Department of the Treasury.

# ACTION:

Application and Renewal Fees Imposed on Surety Companies and Reinsuring Companies Increase in Fees Imposed.

# SUMMARY:

Effective December 31, 2010, The Department of the Treasury, Financial Management Service, is increasing the fees it imposes on and collects from surety companies and reinsuring companies.

# FOR FURTHER INFORMATION CONTACT:

Surety Bond Branch at (202) 874-6850.

# SUPPLEMENTARY INFORMATION:

The fees imposed and collected, as referred to in 31 CFR 223.22, cover the costs incurred by the Government for services performed relative to qualifying corporate sureties to write Federal business. These fees are determined in accordance with the Office of Management and Budget Circular A-25, as amended. The change in fees is the result of a thorough analysis of costs associated with the Surety Bond Branch.

The new fee rate schedule is as follows:

(1) Examination of a company's application for a Certificate of Authority as an acceptable surety or as an acceptable reinsuring company on Federal bonds—$9,300.

(2) Determination of a company's continued qualification for annual renewal of its Certificate of Authority—$5,450.

(3) Examination of a company's application for recognition as an Admitted Reinsurer (except on excess risks running to the United States)—$3,275.

(4) Determination of a company's continued qualification for annual renewal of its authority as an Admitted Reinsurer—$2,325.

Questions concerning this notice should be directed to the Surety Bond Branch, Financial Accounting and Services Division, Financial Management Service, Department of the Treasury, 3700 East West Highway, Room 6F01, Hyattsville, MD 20782, Telephone (202) 874-6850.

Dated: December 27, 2010.

Linda S. Kimberling,

Assistant Commissioner for Management (CFO), Financial Management Service.

[FR Doc. 2010-33061 Filed 1-3-11; 8:45 am]

BILLING CODE 4810-35-M